| 000 | 00000nam 2200000za 4500 |
| 001 | 9.834437 |
| 003 | CaOODSP |
| 005 | 20221107150432 |
| 007 | cr ||||||||||| |
| 008 | 170329s2000 onc #o f000 0 eng d |
| 040 | |aCaOODSP|beng |
| 043 | |an-cn--- |
| 086 | 1 |aRv3-1/4-1-2000E-PDF |
| 245 | 10|aDrugs and biologicals |h[electronic resource]. |
| 260 | |a[Ottawa] : |bCanada Customs and Revenue Agency, |c2000. |
| 300 | |a5 p. |
| 490 | 1 |aGST/HST memoranda series |
| 500 | |aIssued also in French under title: Médicaments et substances biologiques. |
| 500 | |aCaption title. |
| 500 | |a"June 2000." |
| 500 | |aChapter 4.1 of the GST/HST memoranda series. |
| 520 | |a"This memorandum in Chapter 4, Zero-Rated Supplies, supersedes Memorandum 4.1, Prescription Drugs and Biologicals, issued in January 1995. Due to the number of revisions, the changes have not been side-barred. This memorandum explains the tax status of drugs and biologicals as they relate to the Goods and Services Tax /Harmonized Sales Tax (GST/HST) provisions of the Excise Tax Act (the Act)"--p. 1. |
| 692 | 07|2gccst|aGoods and services tax |
| 692 | 07|2gccst|aHarmonized sales tax |
| 710 | 1 |aCanada. |bCanada Customs and Revenue Agency. |
| 775 | 08|tMédicaments et substances biologiques |w(CaOODSP)9.834440 |
| 830 | #0|aGST/HST memoranda series (Online)|w(CaOODSP)9.832238 |
| 856 | 40|qPDF|s172 KB|uhttps://publications.gc.ca/collections/collection_2017/arc-cra/Rv3-1-4-1-2000-eng.pdf |